Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (16)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Qiao, J.
Right arrow Articles by Ho, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qiao, J.
Right arrow Articles by Ho, P. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol 13, 128-131, Copyright © 1998 by Oxford University Press


ARTICLES

The effects of follicular fluid from patients with different indications for IVF treatment on the binding of human spermatozoa to the zona pellucida

J Qiao, WS Yeung, YQ Yao and PC Ho
Department of Obstetrics and Gynaecology, The University of Hong Kong, Queen Mary Hospital, Hong Kong.

This study compared the effects of human follicular fluid (hFF) from women with endometriosis, tubal factor and male factor on the zona binding capacity of human spermatozoa. Samples of hFF were collected from 30 patients, 10 patients for each of the indications of infertility, at the time of oocyte retrieval in an in-vitro fertilization/embryo transfer programme. The hemizona binding assay (HZA) was used to assess the effect of these hFF on the zona binding potential of human spermatozoa. The mean numbers of spermatozoa bound to the zona pellucida after treating the spermatozoa with hFF from endometriosis, tubal factor and male factor were 90.5 +/- 20.9, 108.9 +/- 22.3 and 101.2 +/- 13.4 respectively. These were significantly lower than their corresponding controls, the spermatozoa of which were incubated with Earle's balanced salt solution (endometriosis 238.7 +/- 34.7; tubal factor 210.8 +/- 41.6; male factor 205.4 +/- 26.3; P <0.002). The hemizona binding index (HZI) was similar between male factor samples (52.0 +/- 6.7) and tubal factor samples (53.8 +/- 4.2). Spermatozoa incubated with hFF from endometriosis patients (36.0 +/- 4.1) had an HZI that was significantly lower than those treated with hFF from tubal factor patients (P <0.01). Probably due to small sample size, the differences in HZI between endometriosis samples and male factor samples did not reach statistical significance (P = 0.076). These data suggest that there was a stronger sperm-zona binding inhibitory effect of hFF from patients with endometriosis than from those without the disease.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
L. Safdarian, F. S. Mohammadi, A. Alleyassin, M. Aghahosseini, A. Meysamie, and E. Rahimi
Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916)
Hum. Reprod., September 1, 2007; 22(9): 2449 - 2454.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
T. Jain and R. S. Gupta
Trends in the Use of Intracytoplasmic Sperm Injection in the United States
N. Engl. J. Med., July 19, 2007; 357(3): 251 - 257.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
V. Mitchell, N. Rives, M. Albert, M.-C. Peers, J. Selva, B. Clavier, E. Escudier, and D. Escalier
Outcome of ICSI with ejaculated spermatozoa in a series of men with distinct ultrastructural flagellar abnormalities
Hum. Reprod., August 1, 2006; 21(8): 2065 - 2074.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
G. HALIS and A. ARICI
Endometriosis and Inflammation in Infertility
Ann. N.Y. Acad. Sci., December 1, 2004; 1034(1): 300 - 315.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
ESHRE Capri Workshop Group
Diagnosis and management of the infertile couple: missing information
Hum. Reprod. Update, July 1, 2004; 10(4): 295 - 307.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
P.C.N. Chiu, R. Koistinen, H. Koistinen, M. Seppala, K.F. Lee, and W.S.B. Yeung
Zona-Binding Inhibitory Factor-1 from Human Follicular Fluid Is an Isoform of Glycodelin
Biol Reprod, July 1, 2003; 69(1): 365 - 372.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
J. Tesarik and C. Mendoza
Using the Male Gamete for Assisted Reproduction: Past, Present, and Future
J Androl, May 1, 2003; 24(3): 317 - 328.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. C. N. Chiu, R. Koistinen, H. Koistinen, M. Seppala, K.-F. Lee, and W. S. B. Yeung
Binding of Zona Binding Inhibitory Factor-1 (ZIF-1) from Human Follicular Fluid on Spermatozoa
J. Biol. Chem., April 4, 2003; 278(15): 13570 - 13577.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
J.Y.M. Tse, P.C.N. Chiu, K.F. Lee, M. Seppala, H. Koistinen, R. Koistinen, Y.Q. Yao, and W.S.B. Yeung
The synthesis and fate of glycodelin in human ovary during folliculogenesis
Mol. Hum. Reprod., February 1, 2002; 8(2): 142 - 148.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
M. Luconi, F. Marra, L. Gandini, E. Filimberti, A. Lenzi, G. Forti, and E. Baldi
Phosphatidylinositol 3-kinase inhibition enhances human sperm motility
Hum. Reprod., September 1, 2001; 16(9): 1931 - 1937.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
W. H. Kutteh
Antisperm antibodies: Do antisperm antibodies bound to spermatozoa alter normal reproductive function?
Hum. Reprod., October 1, 1999; 14(10): 2426 - 2429.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.